| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/07/2004 | CA2519479A1 Method for selectively binding a substrate to sorbents by way of at least bivalent bonds |
| 10/07/2004 | CA2519361A1 Method of screening for target ligands |
| 10/07/2004 | CA2519265A1 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 10/07/2004 | CA2518854A1 Treating immunological disorder using agonists of interleukin-21/interleukin-21 receptor |
| 10/07/2004 | CA2518792A1 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 10/07/2004 | CA2518587A1 Multiple-channel test device, method for producing the same and use thereof |
| 10/07/2004 | CA2424629A1 On-line sampling device for ir milk analysis |
| 10/06/2004 | EP1464964A2 Test element holder with a probe guide for an analyzer |
| 10/06/2004 | EP1464963A2 Analyzer having a multifunction reagent rotor |
| 10/06/2004 | EP1464962A2 Colloidal silver-biomolecule complexes |
| 10/06/2004 | EP1464961A1 Methods and reagents for multiplexed analyses of proteins |
| 10/06/2004 | EP1464960A1 Screening Method for the Identification of new Proteome-Interacting Compounds |
| 10/06/2004 | EP1464952A1 Apparatus for stimulating an animal cell and recording its physiological signal and production and use methods thereof |
| 10/06/2004 | EP1464946A1 A testing apparatus and a method for the determination of staple fiber length, shrinkage and crimp properties |
| 10/06/2004 | EP1464945A2 Beaker and method of using it for preparing odour samples |
| 10/06/2004 | EP1464944A1 Liquid sample collection system |
| 10/06/2004 | EP1464943A2 Detection method and detection device of special drugs |
| 10/06/2004 | EP1464710A2 Infectious etiologic agent detection probe and probe set, carrier, and genetic screening method |
| 10/06/2004 | EP1464706A2 HEK5, HEK7, HEK8, HEK11, EPH-like receptor protein tyrosine kinases |
| 10/06/2004 | EP1464700A1 SYSTEM FOR HOUSING/PROCESSING CARRIER AND METHOD FOR HOUSING/PROCESSING CARRIER |
| 10/06/2004 | EP1464677A2 Method for producing low binding surfaces |
| 10/06/2004 | EP1464651A1 Dystrophin-related protein (Drop1), a marker for carcinomas |
| 10/06/2004 | EP1464398A2 Chemical analyzer and structure for chemical analysis |
| 10/06/2004 | EP1464387A2 In situ nucleic acid array synthesis |
| 10/06/2004 | EP1464336A1 Use of tryprostatin A for the reversal of cancer drug resistance |
| 10/06/2004 | EP1464283A1 Blood sampling device with adjustable end cap |
| 10/06/2004 | EP1464234A1 Method for the prevention or reduction of haze in beverages |
| 10/06/2004 | EP1464069A2 Probe for mass spectrometry |
| 10/06/2004 | EP1464022A2 Method for annotating protein sequences |
| 10/06/2004 | EP1463952A2 Quantitative ranking of transient ligand binding to target biomolecules |
| 10/06/2004 | EP1463949A2 Diagnostics and vaccines for mycobacterium paratuberculosis infections |
| 10/06/2004 | EP1463948A2 Uses of an endothelial cell receptor |
| 10/06/2004 | EP1463947A2 Method for reducing non-specific aggregation of latex microparticles in the presence of serum or plasma |
| 10/06/2004 | EP1463946A2 Method for obtaining a unique calibration system applied to multi-parametric doses of biological samples, immunological reagent prepared for that purpose, and dosage method |
| 10/06/2004 | EP1463945A1 Liquid sample assay device |
| 10/06/2004 | EP1463944A2 Method for analyzing effects of medical agents |
| 10/06/2004 | EP1463943A2 Flow-controlled magnetic particle manipulation |
| 10/06/2004 | EP1463939A1 Method for identifying substances, which are marked with deuterated water and whose hydrogen and oxygen isotope ratios are determined by means of mass spectroscopy |
| 10/06/2004 | EP1463938A1 Diagnostic apparatus and methods for a chemical detection system |
| 10/06/2004 | EP1463937A1 Method for analyzing an unknown material as a blend of known materials calculated so as to match certain analytical data and predicting properties of the unknown based on the calculated blend |
| 10/06/2004 | EP1463933A1 Sensor element |
| 10/06/2004 | EP1463930A1 Method and means for correcting measuring instruments |
| 10/06/2004 | EP1463928A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 10/06/2004 | EP1463839A2 Method for detecting human papillomavirus mrna |
| 10/06/2004 | EP1463838A1 Stain-directed molecular analysis for cancer prognosis and diagnosis |
| 10/06/2004 | EP1463833A1 Light-directed molecular analysis for cancer prognosis and diagnosis |
| 10/06/2004 | EP1463832A2 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 86604 |
| 10/06/2004 | EP1463831A2 Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
| 10/06/2004 | EP1463830A2 Method for classification of anti-psychotic drugs |
| 10/06/2004 | EP1463828A1 Method of detection and enumeration of bacteria |
| 10/06/2004 | EP1463827A2 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 10/06/2004 | EP1463826A1 Method for assessing the risk of cardiovascular disease |
| 10/06/2004 | EP1463823A2 Methods of increasing endogenous erythropoietin (epo) |
| 10/06/2004 | EP1463820A1 Method of screening compounds |
| 10/06/2004 | EP1463817A2 Histamine receptor h3 polynucleotides |
| 10/06/2004 | EP1463806A2 Novel cyclooxygenase variants and methods of use |
| 10/06/2004 | EP1463796A1 Microfluidic device and methods of using same |
| 10/06/2004 | EP1463760A2 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 10/06/2004 | EP1463759A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 10/06/2004 | EP1463756A2 Secreted proteins |
| 10/06/2004 | EP1463754A2 Cystine-knot fold protein |
| 10/06/2004 | EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use |
| 10/06/2004 | EP1463744A2 Devices and methods for isolating and detecting specific substances in complex matrices |
| 10/06/2004 | EP1463693A1 Optimized device for the regulation and measurement of gas content in composting platforms or platforms for the treatment of waste with measuring probes |
| 10/06/2004 | EP1463584A1 Multiple analyte assay device with sample integrity monitoring system |
| 10/06/2004 | EP1463576A2 Mesoporous permeation layers for use on active electronic matrix devices |
| 10/06/2004 | EP1463532A2 Dose response-based methods for identifying receptors having alterations in signaling |
| 10/06/2004 | EP1463531A1 Methods for inhibiting ocular processes |
| 10/06/2004 | EP1463526A2 Early detection of mycobacterial disease using peptides |
| 10/06/2004 | EP1463522A1 Human antipneumococcal antibodies from non-human animals |
| 10/06/2004 | EP1463520A2 Immunisation against chlamydia trachomatis |
| 10/06/2004 | EP1463516A2 Identification and characterization of multiple splice variants of the mu opioid receptor gene |
| 10/06/2004 | EP1463512A2 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
| 10/06/2004 | EP1463481A2 Methods and compositions for treatment of central nervous system disorders |
| 10/06/2004 | EP1463480A2 Functionalized materials and libraries thereof |
| 10/06/2004 | EP1424931A4 Early diagnosis of stroke |
| 10/06/2004 | EP1414987A4 Assays for inositol phosphates |
| 10/06/2004 | EP1392915A4 Rapid triglyceride assay for use in pulp pitch control |
| 10/06/2004 | EP1390518B1 Buffer solution for electroporation and a method comprising the use of the same |
| 10/06/2004 | EP1330647B1 A method to determine an engrafting cell dose of hematopoietic stem cell transplant units |
| 10/06/2004 | EP1317668B1 Method for the pyrolysis of mercuric chloride for the subsequent analysis of the mercury |
| 10/06/2004 | EP1307262B1 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity |
| 10/06/2004 | EP1301767B1 Method for the selective determination of blocking auto-antibodies to the tsh receptor |
| 10/06/2004 | EP1279033B1 Electrochemical biosensor test strip with recognition electrode and readout meter using this test strip |
| 10/06/2004 | EP1208189B1 Device and method for analysing liquid samples |
| 10/06/2004 | EP1204763B1 Method for characterizing nucleic acid fragments |
| 10/06/2004 | EP1196780B1 Production and use of luminescent microparticles and nanoparticles |
| 10/06/2004 | EP1173283B1 Centrifuging device and use of same |
| 10/06/2004 | EP1171470B1 Antibodies to placental protein 13 |
| 10/06/2004 | EP1165745A4 Cell activity assay apparatus and methods for making and using same |
| 10/06/2004 | EP1159446A4 Blood serum sample prepared for isolation of prions and prpsc |
| 10/06/2004 | EP1149291A4 Apparatus and method for concurrent chemical synthesis |
| 10/06/2004 | EP1149289B1 Whole cell selection utilizing azlactone-functional supports |
| 10/06/2004 | EP1141402A4 Method for the detection of specific nucleic acid sequences by polymerase nucleotide incorporation |
| 10/06/2004 | EP1137804B9 Method for detecting in vitro a target substance in a sample comprising the labelling of said substance with a reporter gene and the sequences required for expressing said reporter gene in vitro |
| 10/06/2004 | EP1137801B9 Diagnostic method based on the function of a protein produced in a cell-free environement from a nucleic acid sample |
| 10/06/2004 | EP1114870B1 Methods for fractional quantification of cholesterol in lipoproteins and quantification reagents |
| 10/06/2004 | EP1101112B1 Leptin-mediated gene-induction |
| 10/06/2004 | EP1071955B1 Improved immunodiagnostic assays using reducing agents |
| 10/06/2004 | EP1062514B1 C-myc coding region determinant-binding protein (crd-bp) |